{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:56:51Z","timestamp":1789181811338,"version":"build-2803163510"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute kidney injury (AKI) is a serious complication during pediatric cancer treatment. Nephrotoxic medication may increase the risk of developing AKI, which may necessitate modifications to standard treatment and may also increase the risk of chronic kidney disease (CKD). This study investigates the incidence of AKI, the impact of nephrotoxic medications and the association between AKI and the development of CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective national cohort study, we analyzed 1525 pediatric cancer patients treated at the Princess M\u00e1xima Center between 2015 and 2021. AKI was classified using KDIGO criteria based on serum creatinine. The effect of nephrotoxic medications and other risk factors on AKI incidence and progression was assessed by using a cause specific hazard regression model. The cumulative incidence of AKI was estimated with a competing risk model with death as competing event. The effect of risk factors on CKD, defined as an eGFR &amp;lt;90\u00a0ml\/min\/1.73 m\u00b2 1 year after cancer treatment, was evaluated with a logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 1525 patients, 37% experienced AKI. A competing risk model identified treatment with ifosfamide, amphotericin B, acyclovir, and busulfan as strong, independent risk factors for a first episode of AKI. Older age was also associated with an increased risk of AKI.<\/jats:p>\n                    <jats:p>At 1-year follow-up (n\u00a0=\u00a01159), 13.6% had CKD (eGFR &amp;lt;90\u00a0ml\/min\/1.73 m\u00b2), and 2.8% had an eGFR &amp;lt;60. AKI (occurred during treatment) was the strongest predictor of CKD: a single AKI episode increased the risk 2.6-fold, while more episodes increased it nearly 16-fold. Nephrectomy was also identified as independent risk factors for CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Acute kidney injury (AKI) is common in children with cancer and is strongly associated with an increased risk of chronic kidney disease (CKD). Awareness is crucial for high-risk patients, particularly those receiving nephrotoxic medications, with a history of multiple AKI episodes or a prior nephrectomy. Comprehensive monitoring strategies should be implemented at diagnosis, during therapy, and during the post-treatment period to enable early detection and timely intervention, ultimately reducing the risk of AKI and its progression to CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfaf169","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T11:53:24Z","timestamp":1755777204000},"page":"345-352","source":"Crossref","is-referenced-by-count":8,"title":["Nephrotoxicity and kidney outcomes in pediatric oncology patients"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5227-2057","authenticated-orcid":false,"given":"Paulien A M A","family":"Raymakers-Janssen","sequence":"first","affiliation":[{"name":"Wilhelmina Children's Hospital\/ University Medical Center Utrecht Department of Pediatric Intensive Care, , Utrecht ,","place":["The Netherlands"]},{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Leitzinger","sequence":"additional","affiliation":[{"name":"Mathematical Institute, Leiden University , Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Wilhelmina Children's Hospital\/University Medical Center Utrecht Department of Pediatric Nephrology, , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joppe","family":"Nijman","sequence":"additional","affiliation":[{"name":"Wilhelmina Children's Hospital\/ University Medical Center Utrecht Department of Pediatric Intensive Care, , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke I","family":"Triest","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Kilsdonk","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge A","family":"van Kessel","sequence":"additional","affiliation":[{"name":"Wilhelmina Children's Hospital\/ University Medical Center Utrecht Department of Pediatric Intensive Care, , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidwien M","family":"Hanff","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"van Grotel","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc H W A","family":"Wijnen","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelie M","family":"W\u00f6sten-van Asperen","sequence":"additional","affiliation":[{"name":"Wilhelmina Children's Hospital\/ University Medical Center Utrecht Department of Pediatric Intensive Care, , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R","family":"Lilien","sequence":"additional","affiliation":[{"name":"Wilhelmina Children's Hospital\/University Medical Center Utrecht Department of Pediatric Nephrology, , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marry M","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Utrecht ,","place":["The Netherlands"]},{"name":"Division of Child Health, Wilhelmina Children's Hospital\/University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fiocco","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Utrecht ,","place":["The Netherlands"]},{"name":"Mathematical Institute, Leiden University , Leiden ,","place":["The Netherlands"]},{"name":"Leiden University Medical Center Department of Medical Statistics and Bioinformatics, , Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"2026013001370129700_bib1","doi-asserted-by":"publisher","first-page":"e893","DOI":"10.1097\/CCM.0000000000003973","article-title":"Epidemiology and outcome of critically ill pediatric cancer and hematopoietic stem cell transplant patients requiring continuous renal replacement therapy: a retrospective nationwide cohort study","volume":"47","author":"Raymakers-Janssen","year":"2019","journal-title":"Crit Care Med"},{"key":"2026013001370129700_bib2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jpeds.2018.12.023","article-title":"Acute kidney injury in pediatric cancer patients","volume":"208","author":"Park","year":"2019","journal-title":"J Pediatr"},{"key":"2026013001370129700_bib3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/07853890510007205","article-title":"Acute renal failure in cancer patients","volume":"37","author":"Lameire","year":"2005","journal-title":"Ann Med"},{"key":"2026013001370129700_bib4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.suponc.2011.03.008","article-title":"Costs and outcomes of acute kidney injury in critically ill patients with cancer","volume":"9","author":"Lahoti","year":"2011","journal-title":"J Support Oncol"},{"key":"2026013001370129700_bib5","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/s41409-018-0428-6","article-title":"A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation","volume":"54","author":"Benoit","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"2026013001370129700_bib6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2215\/CJN.03530412","article-title":"Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center","volume":"8","author":"Salahudeen","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026013001370129700_bib7","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1056\/NEJMra1613984","article-title":"Acute kidney injury in patients with cancer","volume":"376","author":"Rosner","year":"2017","journal-title":"N Engl J Med"},{"key":"2026013001370129700_bib8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2215\/CJN.08110910","article-title":"Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children","volume":"6","author":"Moffett","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026013001370129700_bib9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ejim.2011.05.005","article-title":"Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study","volume":"22","author":"Christiansen","year":"2011","journal-title":"Eur J Int Med"},{"key":"2026013001370129700_bib10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/sj.bmt.1701388","article-title":"Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT","volume":"22","author":"Kist-van Holthe","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2026013001370129700_bib11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N Engl J Med"},{"key":"2026013001370129700_bib12","author":"KDIGO clinical guideline","year":"2012"},{"key":"2026013001370129700_bib13","first-page":"555","article-title":"Drug-induced acute kidney injury","volume":"11","author":"Schetz","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"2026013001370129700_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup","volume":"13","author":"Chawla","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026013001370129700_bib15","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med"},{"key":"2026013001370129700_bib16","first-page":"1141","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"R.J.","year":"1988","journal-title":"Ann Stats"},{"key":"2026013001370129700_bib17","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1681\/ASN.2020060849","article-title":"Kidney function after treatment for childhood cancer: a report from the St. Jude Lifetime Cohort Study","volume":"32","author":"Green","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026013001370129700_bib18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejca.2021.06.050","article-title":"Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"155","author":"Dieffenbach","year":"2021","journal-title":"Eur J Cancer"},{"key":"2026013001370129700_bib19","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.2215\/CJN.09620911","article-title":"Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors","volume":"7","author":"Knijnenburg","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026013001370129700_bib20","doi-asserted-by":"publisher","first-page":"922","DOI":"10.2215\/CJN.09980912","article-title":"Long-term nephrotoxicity in adult survivors of childhood cancer","volume":"8","author":"Dekkers","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026013001370129700_bib21","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.kint.2022.05.029","article-title":"The Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis examined long-term glomerular dysfunction in childhood cancer survivors","volume":"102","author":"Kooijmans","year":"2022","journal-title":"Kidney Int"},{"key":"2026013001370129700_bib22","article-title":"R Foundation for Statistical Computing V, Austria. R: a language and environment for statistical computing","author":"R Core Team","year":"2021"},{"key":"2026013001370129700_bib23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cmpb.2010.01.001","article-title":"The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models","volume":"99","author":"de Wreede","year":"2010","journal-title":"Comput Methods Programs Biomed"},{"key":"2026013001370129700_bib24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/sj.bmt.1705513","article-title":"Acute renal failure following myeloablative autologous and allogeneic hematopoietic cell transplantation","volume":"38","author":"Lopes","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"2026013001370129700_bib25","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26915","article-title":"High incidence of acute kidney injury during chemotherapy for childhood acute myeloid leukemia","volume":"65","author":"Du Plessis","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2026013001370129700_bib26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1053\/j.ajkd.2004.11.013","article-title":"Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation","volume":"45","author":"Parikh","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2026013001370129700_bib27","doi-asserted-by":"crossref","first-page":"5163789","DOI":"10.1155\/2016\/5163789","article-title":"Acute kidney injury in hematopoietic stem cell transplantation: a review","volume":"2016","author":"Krishnappa","year":"2016","journal-title":"Int J Nephrol"},{"key":"2026013001370129700_bib28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.toxrep.2023.04.005","article-title":"Pretreatment of ellagic acid protects ifosfamide-induced acute nephrotoxicity in rat kidneys: a mitochondrial, histopathological and oxidative stress approaches","volume":"10","author":"Shabani","year":"2023","journal-title":"Toxicol Rep"},{"key":"2026013001370129700_bib29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0140-6736(89)90213-4","article-title":"Nephrotoxicity of ifosfamide in children","volume":"334","author":"Skinner","year":"1989","journal-title":"Lancet"},{"key":"2026013001370129700_bib30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mpo.2950220219","article-title":"Ifosfamide nephrotoxicity in children","volume":"22","author":"Skinner","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"2026013001370129700_bib31","first-page":"1636","article-title":"Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group","volume":"82","author":"Skinner","year":"2000","journal-title":"Br J Cancer"},{"key":"2026013001370129700_bib32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/mpo.10336","article-title":"Chronic ifosfamide nephrotoxicity in children","volume":"41","author":"Skinner","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"2026013001370129700_bib33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/00006454-199908000-00010","article-title":"Amphotericin B lipid complex in pediatric patients with invasive fungal infections","volume":"18","author":"Walsh","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"2026013001370129700_bib34","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.bbmt.2017.11.021","article-title":"Acute Kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation: incidence, risk factors, and outcomes","volume":"24","author":"Koh","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026013001370129700_bib35","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s00431-021-04093-0","article-title":"Factors associated with acyclovir nephrotoxicity in children: data from 472 pediatric patients from the last 10 years","volume":"180","author":"Yalcinkaya","year":"2021","journal-title":"Eur J Pediatr"},{"key":"2026013001370129700_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/pbc.20858","article-title":"Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System","volume":"48","author":"St\u00f6hr","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"2026013001370129700_bib37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"key":"2026013001370129700_bib38","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00467-020-04898-5","article-title":"Urinary neutrophil gelatinase-associated lipocalin rules out nephrotoxic acute kidney injury in children","volume":"36","author":"Goldstein","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"2026013001370129700_bib39","doi-asserted-by":"publisher","first-page":"e2229442","DOI":"10.1001\/jamanetworkopen.2022.29442","article-title":"Consensus-based recommendations on priority activities to address acute kidney injury in children: a modified Delphi Consensus Statement","volume":"5","author":"Goldstein","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026013001370129700_bib40","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.jacc.2014.09.066","article-title":"Combining functional and tubular damage biomarkers improves diagnostic precision for acute kidney injury after cardiac surgery","volume":"64","author":"Basu","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026013001370129700_bib41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.kint.2019.10.015","article-title":"A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children","volume":"97","author":"Goldstein","year":"2020","journal-title":"Kidney Int"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf169\/64110972\/gfaf169.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/2\/345\/64110972\/gfaf169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/2\/345\/64110972\/gfaf169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:37:07Z","timestamp":1769755027000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/2\/345\/8239795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,22]]},"published-print":{"date-parts":[[2026,1,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf169","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,8,22]]}}}